New drugs for cancer therapy at international conference in Amsterdam

Among the drugs that will be discussed in Amsterdam over the next three days are bevacizumab, cetuximab, dasatinib, erlotinib, lapatinib, nilotinib, oblimersen sodium, sorafenib, and sunitinib. All of these have been approved or are awaiting regulatory approval in various cancer indications. In addition, a range of agents in earlier phases of development will be discussed. The TAT 2007 program incorporates presentations of results from early-phase clinical trials (phase I and phase II) that have not been released before.

Targeted anticancer agents are the subject of extensive research and development activities worldwide, often conducted in joint projects of academic research institutes and pharmaceutical companies. These drugs are characterized by the fact that they have a well-defined molecular target, which is known to play a role in the growth of tumors or the blood vessels supplying the tumor with nutrients.

Many leading cancer institutes from all over the world are represented at the TAT 2007 conference in Amsterdam. In total, about 600 delegates from over 40 countries will gather at the VU University Main Building in a conference organized by the Amsterdam-based NDDO Research Foundation in a partnership with the European Society for Medical Oncology (ESMO). Professor Giuseppe Giaccone, VU medical center, Amsterdam, is the President of this Conference.


Contact: Marinus W. Lobbezoo
European Society for Medical Oncology

Page: 1

Related biology news :

1. MIT model could predict cells response to drugs
2. New target for HIV/AIDS drugs and vaccine discovered
3. Modified mushrooms may yield human drugs
4. UGR researchers design an alternative to blood test to detect drugs in the body
5. Could fungal collection hold the key to new life-saving drugs?
6. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
7. Scientists develop new drugs to fight colon and breast cancer more effectively
8. Anti-inflammatory drugs interact with HRT, and more
9. Generic biologic drugs unlikely to offer significant savings
10. Stem cells provide new tool for studying disease and identifying ALS drugs
11. Enhancing chemotherapys efficacy: New agent has synergistic effect with standard drugs

Post Your Comments:

(Date:5/21/2019)... ... May 21, 2019 , ... If a ... know? How can we tell it apart from the millions of microorganisms that ... multi-institution research team, including Eric Young , assistant professor of chemical engineering ...
(Date:5/21/2019)... ... May 21, 2019 , ... Suvoda LLC , a SaaS ... management, has been named one of Inc. Magazine’s Best Workplaces for 2019, Inc.’s fourth ... now featured on Inc.com and hitting the newsstands on May 28, is the result ...
(Date:5/21/2019)... , ... May 20, 2019 , ... Dr. David ... acclaimed documentary. The documentary, Stem Cell Therapy: Biotechnology to the Rescue, was produced by ... long, Dr. Greene was interviewed in regards to the safety of the procedures along ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... fuels, a research team that includes a chemical engineer at Worcester Polytechnic Institute ... microorganism that may make it possible to manufacture isobutanol and other biofuels more ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... systems, applications, and technology, today announced that Bank South Pacific (BSP), the largest ... RFP process. The bank awarded Fulcrum a contract to deliver a fingerprint-based Know ...
(Date:4/12/2019)... ... April 12, 2019 , ... An ... and will educate about innovative tools and devices being used to enhance cognitive ... more information. , This segment of Advancements will focus on Sound for Life, ...
(Date:4/10/2019)... ... 2019 , ... After more than three months of renovation, Lajollacooks4u is set ... updated appliances and modern lighting and fixtures, and will provide additional workspace for the ... tremendous growth in the demand for our team-building events and cooking classes over the ...
Breaking Biology Technology:
Cached News: